Search

Your search keyword '"Quantitative Structure-Activity Relationship"' showing total 1,506 results

Search Constraints

Start Over You searched for: Descriptor "Quantitative Structure-Activity Relationship" Remove constraint Descriptor: "Quantitative Structure-Activity Relationship" Publisher elsevier Remove constraint Publisher: elsevier
1,506 results on '"Quantitative Structure-Activity Relationship"'

Search Results

1. Ionic liquids as the effective technology for enhancing transdermal drug delivery: Design principles, roles, mechanisms, and future challenges

2. Quantitative structure-activity relationship model development for estimating the predicted No-effect concentration of petroleum hydrocarbon and derivatives in the ecological risk assessment

3. Prediction of freshwater ecotoxicological hazardous concentrations of major surfactants using the QSAR–ICE–SSD method

4. Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations

5. Identification of estrogen receptor agonists among hydroxylated polychlorinated biphenyls using classification-based quantitative structure–activity relationship models

6. New insight into biodegradation mechanism of phenylurea herbicides by cytochrome P450 enzymes: Successive N-demethylation mechanism

7. Dataset on aquatic ecotoxicity predictions of 2697 chemicals, using three quantitative structure-activity relationship platforms

8. Identification of bile acids in snake bile by hydrogen/deuterium exchange mass spectrometry and quantitative structure-retention relationship analysis.

9. A new parameter for quantitatively characterizing antibiotic hormesis: QSAR construction and joint toxic action judgment.

10. Machine learning-based q-RASAR predictions of the bioconcentration factor of organic molecules estimated following the organisation for economic co-operation and development guideline 305.

11. Machine learning-driven QSAR models for predicting the cytotoxicity of five common microplastics.

12. Derivation of water quality criteria for paraquat, bisphenol A and carbamazepine using quantitative structure-activity relationship and species sensitivity distribution (QSAR-SSD).

13. Degradation of β-lactam antibiotics by Fe(III)/HSO 3 - system and their quantitative structure-activity relationship.

14. Analysis of implicit and explicit uncertainties in QSAR prediction of chemical toxicity: A case study of neurotoxicity.

15. Advancing toxicity studies of per- and poly-fluoroalkyl substances (pfass) through machine learning: Models, mechanisms, and future directions.

16. Novel mandelic acid derivatives containing piperazinyls as potential candidate fungicides against Monilinia fructicola: Design, synthesis and mechanism study.

17. 4D-QSAR, ADMET properties, and molecular dynamics simulations for designing N-substituted urea/thioureas as human glutaminyl cyclase inhibitors.

18. Food additive salicylates inhibit human and rat placental 3β-hydroxysteroid dehydrogenase: 3D-QSAR and in silico analysis.

19. Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism.

20. In silico development of novel angiotensin-converting-enzyme-I inhibitors by Monte Carlo optimization based QSAR modeling, molecular docking studies and ADMET predictions.

21. Reduced estrogenic risks of a sunscreen additive: Theoretical design and evaluation of functionally improved salicylates.

22. Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.

23. How safe are wild-caught salmons exposed to various industrial chemicals? First ever in silico models for salmon toxicity data gaps filling.

24. From molecular descriptors to the developmental toxicity prediction of pesticides/veterinary drugs/bio-pesticides against zebrafish embryo: Dual computational toxicological approaches for prioritization.

25. In silico degradation of fluoroquinolones by a microalgae-based constructed wetland system.

26. New combined Inverse-QSAR and molecular docking method for scaffold-based drug discovery.

27. Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach.

28. Synthesis, biological evaluation, theoretical calculations, QSAR and molecular docking studies of novel arylaminonaphthols as potent antioxidants and BChE inhibitors.

29. Prediction of chronic toxicity of pharmaceuticals in Daphnia magna by combining ortholog prediction, pharmacological effects, and quantitative structure-activity relationship.

30. Synthesis, Characterization, and Antifungal Evaluation of Thiolactomycin Derivatives

31. Exploration of the quantitative Structure-Activity relationships for predicting Cyclooxygenase-2 inhibition bioactivity by Machine learning approaches

32. Quantitative structure-retention relationships for pyridinium-based ionic liquids used as gas chromatographic stationary phases: convenient software and assessment of reliability of the results.

33. Prediction of retention data of phenolic compounds by quantitative structure retention relationship models under reverse-phase liquid chromatography.

34. The database makes the poison: How the selection of datasets in QSAR models impacts toxicant prediction of higher tier endpoints.

35. In-silico mechanistic analysis of adsorption of Iodinated Contrast Media agents on graphene surface.

36. Synthesis, kinetic studies, and QSAR of dinucleoside polyphosphate derivatives as human AK1 inhibitors.

37. An in silico study on human carcinogenicity mechanism of polybrominated biphenyls exposure.

38. An artificial intelligence-based model for predicting reproductive toxicity of bisphenol analogues mixtures to the rotifer Brachionus calyciflorus.

39. Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity.

40. Chemometrics-driven prediction and prioritization of diverse pesticides on chickens for addressing hazardous effects on public health.

41. Unveiling G-protein coupled receptor kinase-5 inhibitors for chronic degenerative diseases: Multilayered prioritization employing explainable machine learning-driven multi-class QSAR, ligand-based pharmacophore and free energy-inspired molecular simulation.

42. Estimation of passive gastrointestinal absorption of new dual DNA gyrase and topoisomerase IV inhibitors using PAMPA and biopartitioning micellar chromatography and quantitative structure-retention relationship analysis.

43. Prioritizing of potential environmental exposure carcinogens beyond IARC group 1-2B based on weight of evidence (WoE) approach.

44. 3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors.

45. Density functional theory (DFT) studies in HDAC-based chemotherapeutics: Current findings, case studies and future perspectives.

46. Quantitative read-across structure-activity relationship (q-RASAR): A novel approach to estimate the subchronic oral safety (NOAEL) of diverse organic chemicals in rats.

47. QSAR prediction, synthesis, anticancer evaluation, and mechanistic investigations of novel sophoridine derivatives as topoisomerase I inhibitors.

48. An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches.

49. In-silico screening and identification of glycomimetic as potential human sodium-glucose co-transporter 2 inhibitor.

50. Detrimental impacts and QSAR baseline toxicity assessment of Japanese medaka embryos exposed to methylparaben and its halogenated byproducts.

Catalog

Books, media, physical & digital resources